{"resourceType":"Parameters","parameter":[{"name":"evaluation","resource":{"resourceType":"ImmunizationEvaluation","id":"2018-0008-dose1-evaluation","status":"completed","patient":{"reference":"Patient/2018-0008"},"date":"2020-06-29T00:00:00.000","targetDisease":{},"immunizationEvent":{"reference":"Immunization/2018-0008-dose1"},"doseStatus":{"coding":[{"system":"http://terminology.hl7.org/CodeSystem/immunization-evaluation-dose-status","code":"Valid","display":"Valid"}]},"doseStatusReason":[{"coding":[{"system":"http://hl7.org/fhir/us/ImmunizationFHIRDS/CodeSystem/StatusReason","display":""}]}]}},{"name":"evaluation","resource":{"resourceType":"ImmunizationEvaluation","id":"2018-0008-dose2-evaluation","status":"completed","patient":{"reference":"Patient/2018-0008"},"date":"2020-06-29T00:00:00.000","targetDisease":{},"immunizationEvent":{"reference":"Immunization/2018-0008-dose2"},"doseStatus":{"coding":[{"system":"http://terminology.hl7.org/CodeSystem/immunization-evaluation-dose-status","code":"Valid","display":"Valid"}]},"doseStatusReason":[{"coding":[{"system":"http://hl7.org/fhir/us/ImmunizationFHIRDS/CodeSystem/StatusReason","display":""}]}]}},{"name":"recommendation","resource":{"resourceType":"ImmunizationRecommendation","patient":{"reference":"Patient/2018-0008"},"date":"2020-06-29T00:00:00.000","recommendation":[{"targetDisease":[{}],"forecastStatus":{"coding":[{"system":"http://hl7.org/fhir/us/ImmunizationFHIRDS/CodeSystem/ForecastStatus","code":"notComplete","display":"Not Complete"}]},"dateCriterion":[{"code":{"coding":[{"system":"http://loinc.org","code":"30981-5","display":"Earliest date to give"}]},"value":"2020-08-24T00:00:00.000"},{"code":{"coding":[{"system":"http://loinc.org","code":"30980-7","display":"Date vaccine due"}]},"value":"2020-08-24T00:00:00.000"},{"code":{"coding":[{"system":"http://loinc.org","code":"59778-1","display":"Date when overdue for immunization"}]},"value":"2021-02-25T00:00:00.000"}],"description":"Evaluation_Test_Type: Interval: At Absolute Minimum\nForecast_Test_Type: EvaluationRecommended based on minimum interval \nGeneral_Description: This test case describes when a patient is administered the first dose of RZV (Shingrix) at 4 weeks after a previous dose of ZVL (Zostavax), that the dose is considered valid. Per current guidance, RZV is recommended to be spaced 8 weeks after ZVL, but it does not need to be repeated if administered at any point prior to that 8 weeks up to and including the same day.","series":"VaccineGroupName.zoster","doseNumberPositiveInt":3}]}}]}